Isansys Lifecare

What Isansys Lifecare does

Isansys Lifecare is a private medical device and digital health company that develops the Patient Status Engine (PSE), a wireless, end-to-end, regulated platform for continuous real-time patient monitoring in acute care settings. The platform combines wearable biosensors (Lifetouch ECG/HR/respiration patch, Lifetemp continuous temperature sensor, wireless pulse oximeter, and wireless blood pressure monitors) with a Bedside Gateway tablet, a Lifeguard Server backend featuring an open API for EMR integration, a Remote Lifeguard module for 24/7 off-site monitoring, and a multi-channel Notification Service (SMS, WhatsApp, provider apps). The system is FDA-cleared Class II, CE-marked Class IIa, UKCA-marked, and CDSCO-registered, and the company claims it is the only wireless monitoring platform where the wireless connections are part of the regulated certification.

The company's commercial focus is on large hospital systems and academic research institutions. Named enterprise customers span India's largest hospital chains (Apollo, Fortis, Manipal, Max Healthcare, Aretè), UK NHS trusts (Christie NHS Foundation Trust, NHS Liverpool), Scandinavia (St. Olav's Hospital, Sorlandet, NTNU), Australia (Queensland Health), Singapore (National University Hospital), and Germany, with academic collaborations including Aston University, the University of Glasgow, and the University of Applied Science. Disclosed outcomes include zero ICU readmissions, an 8% Code Blue reduction, and significant nursing time savings per shift from automated vitals capture.

Revenue mechanics are split between hardware sales of PSE sensor kits and gateways and an underlying subscription/recurring component covering software updates, Lifeguard Server access, and remote monitoring services. The go-to-market is enterprise-direct field sales to hospital procurement and clinical leadership, with no public pricing, no disclosed revenue figures, and no disclosed venture funding rounds since a £1.2M Innovate UK grant in February 2016; prior SBRI Healthcare awards total roughly £2.5M ($3.2M) across 2013 and 2015. The company rebranded and refocused operations as 'Isansys India' in 2025 with headquarters in Bengaluru, while retaining an operational and customer footprint across the UK and other markets. The co-founder and CEO is Keith Errey.

Name

Isansys Lifecare

Legal name

Isansys Lifecare

Website

https://isansys.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Wireless Patient Monitoring Systems

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Home Health Care Services (62161)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro industry

PRIMARYHLACAPAI

Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)

Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring

SECONDARYHLALABAF

Chronic Care & Remote Patient Monitoring (RPM) Platforms

Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)

SECONDARYHLALAFAH

Hospital-at-Home & Acute-at-Home Remote Monitoring (step-down, escalation workflows)

Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms

Keywords

• Wireless patient monitoring
• Medical device platform
• Remote patient monitoring
• Clinical decision support
• Wearable biosensors

Headquarters

HQ city

Abingdon

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales

Revenue model

1. Patient Status Engine Platform: Isansys generates revenue through sale and deployment of its Patient Status Engine platform, which includes wireless sensors (Lifetouch, Lifetemp, pulse oximeter, blood pressure monitors), bedside gateway, and Lifeguard server software. The platform is sold as a complete regulated medical device system to healthcare providers.
2. Software Platform/Subscription: The PSE platform includes continuous software updates, remote monitoring capabilities, and cloud connectivity through the Lifeguard Server, suggesting recurring revenue components for software access, monitoring services, and platform maintenance.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Isansys Lifecare designs, manufactures, and sells the Patient Status Engine (PSE), an all-wireless, end-to-end fully-regulated medical device platform for continuous real-time patient monitoring. The platform combines wearable biosensors (Lifetouch, Lifetemp, pulse oximeter, blood pressure monitors), a bedside gateway, and a back-end Lifeguard Server with open API to capture, transmit, and analyse physiological data, generating automated Early Warning Scores and AI-driven predictive analytics for hospitals and healthcare providers.

Product overview

Isansys offers the Patient Status Engine (PSE), a unified wireless patient monitoring platform combining sensors, connectivity, and clinical AI. The portfolio includes the Lifetouch biosensor (ECG, heart rate, respiration, HRV), Lifetemp temperature sensor, wireless pulse oximeter, and blood pressure monitors as wearable sensing devices. These connect via Bluetooth to the Bedside Gateway tablet, which transmits data via Wi-Fi/3G/4G to the Lifeguard Server backend with open API. The Remote Lifeguard module provides 24/7 remote monitoring access, while the Notification Service delivers alerts via SMS and WhatsApp. The platform continuously processes vital signs using predictive analytics to generate Early Warning Scores and predict patient deterioration hours in advance.

Differentiator

Problem solved

Functional benefit

Products and services

• Patient Status Engine (PSE) An all-wireless, end-to-end fully-regulated medical device platform for real-time physiological data capture and analysis. Frees patients and care teams from cables and is continually upgradable. FDA-cleared Class II, CE-marked Class IIa, UKCA-marked, and CDSCO registered. Designed for hospitals and healthcare providers seeking universal patient data capture and analysis infrastructure.
• Lifetouch Intelligent Wearable Biosensor A validated and clinically proven wireless medical device biosensor that continuously samples and analyses ECG signals in the sensor itself to extract heart rate, respiration rate, and HRV. Includes a 3-axis accelerometer for patient orientation, activity, and motion monitoring. Supports at least three days of continuous use with real-time ECG streaming. Over 150,000 hours of data have been collected from patients in acute care settings using this device.
• Lifetemp Continuous Temperature Sensor

Quantifiable outcome

• 0% ICU readmission reported
• +4 more outcomes

Named customers17 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature10 records

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Philips (Patient Monitoring): Philips is one of the largest global patient monitoring vendors with a broad portfolio of wired and wireless ICU and ward monitoring solutions, EMR integration and clinical decision support. It competes with Isansys' PSE in the same hospital buyer segment and represents the dominant incumbent Isansys must displace or co-exist with.
• GE HealthCare (Patient Monitoring): GE HealthCare offers a full suite of bedside and central station patient monitoring, including wireless telemetry and EMR-integrated early warning scoring. It targets the same hospital procurement committees as Isansys and serves as a benchmark for incumbent breadth and installed base.
• Mindray: Mindray is a global medical device vendor offering multi-parameter patient monitors, wireless wearables and central monitoring stations across emerging and developed markets. Its competitive overlap with Isansys is direct in wireless vital signs monitoring and pricing-sensitive hospital segments, especially in Asia.
• Dräger: Dräger supplies anaesthesia, ventilation and patient monitoring systems widely used in European hospitals, including integrated wireless and wearable monitoring options. It competes with Isansys in the same European acute-care buyer segment, particularly in NHS and Nordic accounts.

Direct peers

• Masimo: Masimo is a leading vendor of pulse oximetry, capnography and continuous patient monitoring sensors, with a strong installed base in hospitals and growing wireless offerings. It overlaps directly with Isansys on SpO2, sensor-level analytics and integration with bedside monitoring platforms.
• VitalConnect: VitalConnect offers the VitalPatch wearable biosensor and VistaCenter platform for continuous multi-parameter remote monitoring in both hospital and home settings. Its architecture, sensors and AI-driven EWS workflow closely mirror Isansys' PSE positioning.
• EarlySense: EarlySense provides contact-free and wearable continuous patient monitoring with early warning scores for hospital wards and post-acute settings. It targets similar use cases to Isansys (deterioration detection, nursing workload reduction) with comparable sensor-plus-software value propositions.

Emerging players

• iRhythm Technologies: iRhythm provides wearable cardiac monitoring (e.g., Zio) with AI-driven arrhythmia detection and a remote reporting service. It is comparable to Isansys in combining a wearable biosensor with AI analytics for continuous monitoring, though it is more focused on ambulatory cardiac diagnostics than multi-parameter acute care.
• Biofourmis: Biofourmis combines wearable biosensors with AI-driven analytics for hospital-at-home and post-discharge remote monitoring. It overlaps with Isansys' remote monitoring and predictive deterioration use cases, particularly in the home and virtual ward segments.
• Huma (formerly Medopad): Huma provides a regulated remote patient monitoring and digital health platform with wearable integration, used by hospitals and pharma for decentralized care. It is comparable to Isansys in the RPM-plus-clinical-decision-support category, with a stronger software/SaaS orientation.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@isansyslifecare285
• LinkedInlinkedin.com/company/isansys-lifecare-ltd
• Xx.com/isansys
• Facebookfacebook.com/827954420560362

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds3 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Isansys Lifecare